Income Statement ORAPI CBOE

Stocks

0ICI

FR0000075392

Commodity Chemicals

End-of-day quote CBOE
- ^EUR	-

20/12/24	Orapi SA(ENXTPA:ORAP) dropped from CAC AllShares Index	CI
10/10/24	Orapi: proposed public exchange offer filed with the AMF

7cc803173aebd658cc6df1c29bd2f._BUMIdyXKSbCzbBKukjNc0gip5_eVpR34ZCHEKjpkYE.ilt-GIrOf3Lvu4cr8B6SPx5MxK-tGsZGisf_defd28iQXk5g6vpCb7b8hA

Published financial data: ORAPI

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	240M	268M	227M	230M	229M
Total Revenues	240M	268M	227M	230M	229M
Cost of Goods Sold, Total	125M	127M	112M	120M	124M
Gross Profit	115M	141M	115M	109M	105M
Selling General & Admin Expenses, Total	96.71M	105M	92.88M	91.31M	87.04M
Depreciation & Amortization - (IS)	13.03M	12.81M	12.02M	-	13.48M
Other Operating Expenses	2.1M	4.83M	1.28M	14.29M	7.4M
Other Operating Expenses, Total	112M	122M	106M	106M	108M
Operating Income	2.94M	18.6M	8.83M	3.69M	-2.91M
Interest Expense, Total	-3.53M	-2.93M	-4.37M	-869K	-880K
Interest And Investment Income	101K	41K	31K	22K	58K
Net Interest Expenses	-3.43M	-2.89M	-4.34M	-847K	-822K
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-30K	-74K	-178K	38K	13K
Other Non Operating Income (Expenses)	-14K	-2.29M	-1.68M	-816K	-1.42M
EBT, Excl. Unusual Items	-527K	13.34M	2.63M	2.06M	-5.14M
Restructuring Charges	-2.02M	-1.32M	-444K	-161K	-50K
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-6.14M	-	-500K	-711K	-13.02M
Gain (Loss) On Sale Of Assets	6.39M	1.2M	-578K	-	-39K
Legal Settlements	329K	-	-	-	-
Other Unusual Items	-146K	-228K	-	-	-
EBT, Incl. Unusual Items	-2.11M	13M	1.11M	1.19M	-18.26M
Income Tax Expense	806K	3.54M	717K	267K	90K
Earnings From Continuing Operations	-2.91M	9.46M	394K	926K	-18.35M
Earnings Of Discontinued Operations	-	-	-	-	-134K
Net Income to Company	-2.91M	9.46M	394K	926K	-18.48M
Minority Interest	-45K	-241K	-199K	-121K	-338K
Net Income - (IS)	-2.96M	9.22M	195K	805K	-18.82M
Net Income to Common Incl Extra Items	-2.96M	9.22M	195K	805K	-18.82M
Net Income to Common Excl. Extra Items	-2.96M	9.22M	195K	805K	-18.68M
Per Share Items
Net EPS - Basic	-0.64	1.7	0.03	0.12	-2.89
Basic EPS - Continuing Operations	-0.64	1.7	0.03	0.12	-2.87
Basic Weighted Average Shares Outstanding	4.59M	5.44M	6.52M	6.51M	6.51M
Net EPS - Diluted	-0.64	1.7	0.03	0.12	-2.89
Diluted EPS - Continuing Operations	-0.64	1.7	0.03	0.12	-2.87
Diluted Weighted Average Shares Outstanding	4.59M	5.44M	6.52M	6.51M	6.51M
Normalized Basic EPS	-0.08	1.49	0.22	0.18	-0.55
Normalized Diluted EPS	-0.08	1.49	0.22	0.18	-0.55
Dividend Per Share	-	-	-	-	-
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	15.06M	24.49M	14.5M	9.04M	3.38M
EBITA	3.64M	19.28M	9.49M	4.33M	-2.26M
EBIT	2.94M	18.6M	8.83M	3.69M	-2.91M
EBITDAR	-	31.42M	20.88M	15.38M	10.28M
Effective Tax Rate - (Ratio)	-38.24	27.23	64.54	22.38	-0.49
Total Current Taxes	1.4M	3.66M	828K	127K	719K
Total Deferred Taxes	-590K	-116K	-111K	140K	-629K
Normalized Net Income	-374K	8.1M	1.45M	1.17M	-3.55M
Interest on Long-Term Debt	-	4.1M	4.31M	830K	844K
Non-Cash Pension Expense	127K	-454K	-712K	-521K	-284K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.13M	1.35M	1.41M	1.62M	1.27M
Net Rental Expense, Total	-	6.93M	6.38M	6.34M	6.9M
Imputed Operating Lease Interest Expense	-	1.75M	2.86M	696K	687K
Imputed Operating Lease Depreciation	-	5.18M	3.52M	5.64M	6.21M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	9.38M	37.85M	10.77M	9.07M	13.24M
Total Cash And Short Term Investments	9.38M	37.85M	10.77M	9.07M	13.24M
Accounts Receivable, Total	42.38M	42.45M	35.54M	39.09M	36.01M
Other Receivables	14.22M	14.41M	11.72M	12.26M	10.28M
Total Receivables	56.6M	56.86M	47.26M	51.35M	46.3M
Inventory	28.58M	35.82M	31.88M	36.51M	31.28M
Other Current Assets, Total	-	-	-	-1K	-
Total Current Assets	94.56M	131M	89.91M	96.93M	90.82M
Gross Property Plant And Equipment	83.9M	89.46M	99.64M	107M	127M
Accumulated Depreciation	-43.49M	-48.58M	-52.74M	-59.02M	-67.76M
Net Property Plant And Equipment	40.41M	40.88M	46.9M	47.85M	59.2M
Long-term Investments	5.06M	3.82M	2.6M	2.57M	2.42M
Goodwill	44.58M	43.8M	37.7M	36.92M	23.92M
Other Intangibles, Total	6.98M	6.61M	6.34M	6.3M	6.16M
Deferred Tax Assets Long-Term	1.26M	1.3M	1.18M	774K	1.96M
Other Long-Term Assets, Total	1K	1K	-2K	1K	-
Total Assets	193M	227M	185M	191M	184M
Liabilities
Accounts Payable, Total	38.39M	44.56M	38.51M	42.69M	42.03M
Accrued Expenses, Total	10.69M	15.76M	13.02M	-	13.37M
Short-term Borrowings	13.39M	14.79M	14.26M	17.51M	16.7M
Current Portion of Long-Term Debt	53.18M	2.25M	2.01M	1.49M	1.12M
Current Portion of Leases	5.54M	5.14M	5M	5.83M	5.34M
Current Income Taxes Payable	1.06M	1.85M	671K	431K	351K
Other Current Liabilities	3.86M	5.91M	5.6M	18.84M	5.07M
Total Current Liabilities	126M	90.26M	79.08M	86.8M	83.98M
Long-Term Debt	4.2M	54.61M	18.34M	19.21M	18.17M
Long-Term Leases	15.29M	16.93M	22.43M	20.49M	35.35M
Pension & Other Post Retirement Benefits	5.14M	5.36M	3.89M	2.76M	3.09M
Deferred Tax Liability Non Current	943K	924K	937K	728K	1.35M
Other Non Current Liabilities	538K	521K	303K	264K	256K
Total Liabilities	152M	169M	125M	130M	142M
Common Stock, Total	4.62M	6.6M	6.6M	6.64M	6.64M
Additional Paid In Capital	35.1M	42.19M	42.22M	42.38M	42.38M
Retained Earnings	-2.96M	9.22M	195K	805K	-18.82M
Treasury Stock	-484K	-461K	-829K	-1.03M	-984K
Comprehensive Income and Other	3.78M	-53K	10.43M	11.25M	11.8M
Total Common Equity	40.06M	57.49M	58.62M	60.04M	41.02M
Minority Interest	542K	839K	1.04M	1.05M	1.26M
Total Equity	40.6M	58.33M	59.66M	61.1M	42.28M
Total Liabilities And Equity	193M	227M	185M	191M	184M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.6M	6.57M	6.53M	6.52M	6.51M
ECS Total Common Shares Outstanding	4.59M	6.58M	6.53M	6.52M	6.51M
Book Value / Share	8.72	8.74	8.98	9.21	6.3
Tangible Book Value	-11.49M	7.09M	14.57M	16.82M	10.94M
Tangible Book Value Per Share	-2.5	1.08	2.23	2.58	1.68
Total Debt	91.61M	93.72M	62.05M	64.54M	76.69M
Net Debt	82.23M	55.87M	51.28M	55.47M	63.44M
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.14M	5.36M	3.89M	2.76M	3.09M
Debt Equivalent Oper. Leases	-	55.43M	51.08M	50.72M	55.16M
Minority Interest, Total (Incl. Fin. Div)	542K	839K	1.04M	1.05M	1.26M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	6.09M	9.34M	9.92M	11.18M	10.8M
Inventories - Finished Goods, Total	26.54M	32.22M	27.5M	30.14M	28.06M
Land - (BS)	3.36M	3.31M	3.32M	3.32M	3.32M
Buildings, Total	9.89M	9.69M	9.92M	10.19M	11.78M
Machinery, Total	27.66M	27.48M	28.13M	28.2M	33.79M
Full Time Employees	1.13K	1.11K	1.01K	965	916
Accumulated Allowance for Doubtful Accounts (Supple)	2.93M	3.3M	2.42M	2.1M	2.21M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-2.96M	9.22M	195K	805K	-18.82M
Depreciation & Amortization - CF	17.82M	11.61M	10.85M	10.46M	11.95M
Amortization of Goodwill and Intangible Assets - (CF)	695K	686K	665K	637K	648K
Depreciation & Amortization, Total	18.51M	12.29M	11.52M	11.09M	12.6M
Amortization of Deferred Charges, Total - (CF)	620K	560K	502K	600K	881K
(Gain) Loss From Sale Of Asset	-6.39M	-1.05M	373K	14K	-39K
Asset Writedown & Restructuring Costs	-	-	500K	711K	15.05M
Net Cash From Discontinued Operations	-	-	-	-	-134K
Other Operating Activities, Total	732K	743K	338K	735K	2.14M
Change In Accounts Receivable	5.12M	-679K	5.58M	-3.51M	3.08M
Change In Inventories	5.39M	-7.61M	3.5M	-4.63M	4.71M
Change In Accounts Payable	-13.3M	6.63M	-5.37M	4.26M	-666K
Change in Other Net Operating Assets	-321K	9.02M	101K	-739K	1.77M
Cash from Operations	7.4M	29.12M	17.24M	9.34M	20.57M
Capital Expenditure	-4.34M	-5.94M	-6.84M	-8.26M	-6.24M
Sale of Property, Plant, and Equipment	83K	572K	242K	98K	38K
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	14.29M	1.82M	5.51M	-296K	-46K
Other Investing Activities, Total	7K	48K	-75K	-96K	-
Cash from Investing	10.04M	-3.5M	-1.17M	-8.56M	-6.24M
Short Term Debt Issued, Total	-	1.57M	-	2.95M	-
Long-Term Debt Issued, Total	1.07M	53.4M	-	1.97M	-
Total Debt Issued	1.07M	54.97M	-	4.92M	-
Short Term Debt Repaid, Total	-2.43M	-	-744K	-	-438K
Long-Term Debt Repaid, Total	-15.43M	-60.92M	-43.01M	-8.03M	-8.3M
Total Debt Repaid	-17.86M	-60.92M	-43.76M	-8.03M	-8.74M
Issuance of Common Stock	-	9.27M	28K	203K	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-1.1M
Cash from Financing	-16.8M	3.31M	-43.73M	-2.91M	-9.84M
Foreign Exchange Rate Adjustments	249K	-307K	426K	58K	57K
Miscellaneous Cash Flow Adjustments	1K	-162K	-	-	-
Net Change in Cash	892K	28.47M	-27.23M	-2.07M	4.55M
Supplemental Items
Cash Interest Paid	-	-	-	-	1.1M
Levered Free Cash Flow	17.65M	23.28M	11.23M	644K	14M
Unlevered Free Cash Flow	19.86M	25.11M	13.96M	1.19M	14.55M
Change In Net Working Capital	-3.22M	-6.57M	-3.26M	4.55M	-9.13M
Net Debt Issued / Repaid	-16.8M	-5.96M	-43.76M	-3.11M	-8.74M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	0.93	5.54	2.68	1.23	-0.97
Return on Total Capital	1.44	8.18	4.02	1.86	-1.49
Return On Equity %	-6.97	19.12	0.67	1.53	-35.49
Return on Common Equity	-7.14	18.89	0.33	1.36	-36.98
Margin Analysis
Gross Profit Margin %	47.81	52.67	50.75	47.6	45.84
SG&A Margin	40.28	39.12	40.98	39.77	37.99
EBITDA Margin %	6.27	9.15	6.4	3.94	1.48
EBITA Margin %	1.52	7.21	4.19	1.88	-0.99
EBIT Margin %	1.23	6.95	3.89	1.61	-1.27
Income From Continuing Operations Margin %	-1.21	3.54	0.17	0.4	-8.01
Net Income Margin %	-1.23	3.45	0.09	0.35	-8.21
Net Avail. For Common Margin %	-1.23	3.45	0.09	0.35	-8.16
Normalized Net Income Margin	-0.16	3.03	0.64	0.51	-1.55
Levered Free Cash Flow Margin	7.35	8.7	4.95	0.28	6.11
Unlevered Free Cash Flow Margin	8.27	9.39	6.16	0.52	6.35
Asset Turnover
Asset Turnover	1.22	1.27	1.1	1.22	1.22
Fixed Assets Turnover	7.83	6.58	5.16	4.85	4.28
Receivables Turnover (Average Receivables)	5.32	6.31	5.81	6.15	6.1
Inventory Turnover (Average Inventory)	4.01	3.93	3.3	3.52	3.66
Short Term Liquidity
Current Ratio	0.75	1.45	1.14	1.12	1.08
Quick Ratio	0.52	1.05	0.73	0.7	0.71
Operating Cash Flow to Current Liabilities	0.06	0.32	0.22	0.11	0.24
Days Sales Outstanding (Average Receivables)	68.57	58.03	62.81	59.32	59.83
Days Outstanding Inventory (Average Inventory)	91.1	93.07	110.7	103.76	99.7
Average Days Payable Outstanding	138.82	113.4	140.79	118.63	130.08
Cash Conversion Cycle (Average Days)	20.84	37.71	32.71	44.45	29.44
Long Term Solvency
Total Debt/Equity	225.64	160.66	104	105.63	181.39
Total Debt / Total Capital	69.29	61.64	50.98	51.37	64.46
LT Debt/Equity	48.02	122.64	68.34	64.98	126.59
Long-Term Debt / Total Capital	14.75	47.05	33.5	31.6	44.99
Total Liabilities / Total Assets	78.95	74.29	67.69	68.07	77.08
EBIT / Interest Expense	0.83	6.35	2.02	4.25	-3.31
EBITDA / Interest Expense	6.08	10.55	4.66	17.01	11.01
(EBITDA - Capex) / Interest Expense	4.85	8.52	3.09	7.5	3.92
Total Debt / EBITDA	4.27	3.03	3.05	4.37	7.92
Net Debt / EBITDA	3.83	1.81	2.52	3.75	6.55
Total Debt / (EBITDA - Capex)	5.35	3.76	4.6	9.9	22.22
Net Debt / (EBITDA - Capex)	4.8	2.24	3.8	8.51	18.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.19	11.42	-15.28	1.31	0.89
Gross Profit, 1 Yr. Growth %	-6.26	22.73	-18.37	-4.96	-1.98
EBITDA, 1 Yr. Growth %	48.67	58.42	-41.56	-41.67	-64.65
EBITA, 1 Yr. Growth %	31.48	555.18	-51.59	-50.97	-162.64
EBIT, 1 Yr. Growth %	6.36	531.87	-53.35	-58.19	-180.59
Earnings From Cont. Operations, 1 Yr. Growth %	-21.73	-424.54	-95.83	135.03	-2.25K
Net Income, 1 Yr. Growth %	-21.24	-411.46	-97.88	312.82	-2.44K
Normalized Net Income, 1 Yr. Growth %	352.42	-2.26K	-84.89	-19.15	-416.17
Diluted EPS Before Extra, 1 Yr. Growth %	-21.46	-363.25	-98.23	301.26	-2.74K
Accounts Receivable, 1 Yr. Growth %	-11.37	0.17	-16.29	10.01	-7.89
Inventory, 1 Yr. Growth %	-15.85	25.34	-10.99	14.52	-14.34
Net Property, Plant and Equip., 1 Yr. Growth %	93.45	1.15	14.74	2.03	23.71
Total Assets, 1 Yr. Growth %	-4.4	17.68	-18.58	3.63	-3.6
Tangible Book Value, 1 Yr. Growth %	-26.98	-161.7	93.88	15.46	-34.94
Common Equity, 1 Yr. Growth %	-6.55	43.52	1.21	2.43	-31.68
Cash From Operations, 1 Yr. Growth %	293.04	293.47	-40.8	-45.83	105.24
Capital Expenditures, 1 Yr. Growth %	-42.8	36.82	15.26	20.73	-24.54
Levered Free Cash Flow, 1 Yr. Growth %	-237.98	31.86	-49.14	-94.51	2.25K
Unlevered Free Cash Flow, 1 Yr. Growth %	-280.05	26.44	-44.86	-91.79	1.18K
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.75	2.24	-2.84	-7.36	0.54
Gross Profit, 2 Yr. CAGR %	-2.97	7.26	0.09	-11.92	-4.44
EBITDA, 2 Yr. CAGR %	14.9	55.5	-3.15	-39.63	-53.3
EBITA, 2 Yr. CAGR %	-7.41	163.98	79.58	-53.02	-49.38
EBIT, 2 Yr. CAGR %	-16.73	159.24	73.18	-55.84	-42.58
Earnings From Cont. Operations, 2 Yr. CAGR %	18.31	59.38	-63.23	-68.7	582.37
Net Income, 2 Yr. CAGR %	18.53	56.62	-74.33	-70.44	882.36
Normalized Net Income, 2 Yr. CAGR %	-30.96	889.35	96.57	-65.05	56.69
Diluted EPS Before Extra, 2 Yr. CAGR %	18.32	43.79	-78.45	-73.35	879.53
Accounts Receivable, 2 Yr. CAGR %	-4.46	-5.78	-8.43	-4.04	0.66
Inventory, 2 Yr. CAGR %	-8.37	2.7	5.62	0.96	-0.96
Net Property, Plant and Equip., 2 Yr. CAGR %	39.89	39.88	7.73	8.2	12.35
Total Assets, 2 Yr. CAGR %	-0.94	6.07	-2.15	-8.14	-0.05
Tangible Book Value, 2 Yr. CAGR %	-22.7	-32.88	12.59	49.61	-13.33
Common Equity, 2 Yr. CAGR %	-7.09	15.81	20.97	1.82	-16.35
Cash From Operations, 2 Yr. CAGR %	6.9	293.26	52.63	-43.37	9.24
Capital Expenditures, 2 Yr. CAGR %	-30.2	-11.53	25.58	17.96	-4.55
Levered Free Cash Flow, 2 Yr. CAGR %	175.2	34.88	-20.25	-82.92	9.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	124.4	50.88	-16.17	-78.34	0.34
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.09	3.15	-3.97	-1.48	-5.04
Gross Profit, 3 Yr. CAGR %	-3.12	4.93	-2.07	-1.62	-9.33
EBITDA, 3 Yr. CAGR %	12.59	29.01	12.71	-16.37	-48.54
EBITA, 3 Yr. CAGR %	6.97	65.62	50.81	13.71	-51.32
EBIT, 3 Yr. CAGR %	-0.33	63.64	47.2	7.83	-46.42
Earnings From Cont. Operations, 3 Yr. CAGR %	39.78	65.61	-52.7	-31.76	24.74
Net Income, 3 Yr. CAGR %	39.12	63.57	-62.7	-35.2	26.89
Normalized Net Income, 3 Yr. CAGR %	148.15	117.67	159.54	46.19	-28.15
Diluted EPS Before Extra, 3 Yr. CAGR %	38.96	54.47	-66.84	-42.88	19.3
Accounts Receivable, 3 Yr. CAGR %	-3.55	-2.94	-9.42	-2.65	-5.34
Inventory, 3 Yr. CAGR %	-5.35	1.72	-2.08	8.51	-4.42
Net Property, Plant and Equip., 3 Yr. CAGR %	29.34	25.56	30.94	5.79	13.14
Total Assets, 3 Yr. CAGR %	-0.5	4.92	-2.9	-0.26	-6.65
Tangible Book Value, 3 Yr. CAGR %	-13.2	-28.29	-2.54	13.54	13.35
Common Equity, 3 Yr. CAGR %	-6.38	7.4	11	14.44	-10.86
Cash From Operations, 3 Yr. CAGR %	37.4	65.05	109.2	8.06	-10.94
Capital Expenditures, 3 Yr. CAGR %	-4.73	-12.65	-3.38	23.94	1.64
Levered Free Cash Flow, 3 Yr. CAGR %	96.14	115.35	-4.27	-66.83	-14.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	222.96	85.34	8.16	-60.9	-16.84
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.74	-0.71	-1.79	-1.19	-2.19
Gross Profit, 5 Yr. CAGR %	-0.82	0.25	-1.85	-2.16	-3.03
EBITDA, 5 Yr. CAGR %	5.51	20.47	6.57	-4.54	-19.7
EBITA, 5 Yr. CAGR %	-12.08	46.99	26.14	0.39	-3.95
EBIT, 5 Yr. CAGR %	-15.73	45.93	24.32	-2.76	1.01
Earnings From Cont. Operations, 5 Yr. CAGR %	8.38	10.98	-18.07	-14.96	37.57
Net Income, 5 Yr. CAGR %	8.77	10.58	-29.24	-17.5	38.02
Normalized Net Income, 5 Yr. CAGR %	-34.02	219.71	126.07	8.29	112.1
Diluted EPS Before Extra, 5 Yr. CAGR %	3.21	5.13	-34.07	-23.57	28.47
Accounts Receivable, 5 Yr. CAGR %	0.16	-3.75	-5.53	-3.38	-5.51
Inventory, 5 Yr. CAGR %	-0.5	-0.86	-1.11	1.41	-1.63
Net Property, Plant and Equip., 5 Yr. CAGR %	17.22	14.79	20.22	18.3	23.16
Total Assets, 5 Yr. CAGR %	3.76	1.95	-1.16	-0.53	-1.77
Tangible Book Value, 5 Yr. CAGR %	36.29	-15.77	-3.68	-2.64	-7.01
Common Equity, 5 Yr. CAGR %	-4.12	2.42	3.72	5.29	-0.88
Cash From Operations, 5 Yr. CAGR %	0.03	59.78	43.3	7.59	61.32
Capital Expenditures, 5 Yr. CAGR %	-6.16	-2.18	6.4	-1.49	-3.85
Levered Free Cash Flow, 5 Yr. CAGR %	57.04	98.6	36.84	-22.68	1.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	44.33	93.85	88.3	-21.34	5.7
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-